Opko Health Inc (OPK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -194,423 | -216,054 | -67,613 | -53,224 | -67,251 |
| Depreciation Amortization | 74,351 | 51,473 | 23,917 | 100,150 | 75,465 |
| Income taxes - deferred | -4,850 | -23,137 | -7,424 | 14,744 | 7,695 |
| Accounts receivable | 23,504 | 19,115 | 22,930 | -220 | 15,680 |
| Accounts payable and accrued liabilities | 2,843 | 8,087 | 11,475 | -20,662 | -6,527 |
| Other Working Capital | -29,053 | -27,173 | 10,698 | 32,175 | 49,151 |
| Other Operating Activity | -24,993 | 69,715 | -28,537 | -256,452 | -213,293 |
| Operating Cash Flow | $-152,621 | $-117,974 | $-34,554 | $-183,489 | $-139,080 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | N/A | 166,604 | -1,454 |
| PPE Investments | -9,418 | -6,296 | -3,127 | -24,768 | -19,428 |
| Purchase Of Investment | -7,665 | -7,665 | -8,000 | N/A | N/A |
| Sale Of Investment | 51,655 | 51,655 | 51,655 | N/A | 46,731 |
| Other Investing Activity | 197,770 | 0 | 0 | 210,378 | 210,378 |
| Investing Cash Flow | $232,342 | $37,694 | $40,528 | $352,214 | $236,227 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 24,505 | 16,636 | 5,610 | 459,432 | 448,459 |
| Debt Issued | N/A | N/A | N/A | 480,000 | 480,000 |
| Debt Repayment | -62,382 | -62,382 | -174 | -176,389 | -151,168 |
| Common Stock Issued | -123 | -123 | 88 | -208 | -208 |
| Common Stock Repurchased | -33,533 | -18,255 | N/A | -90,223 | -73,759 |
| Other Financing Activity | -28,184 | -19,387 | -9,546 | -488,446 | -478,686 |
| Financing Cash Flow | $-99,717 | $-83,511 | $-4,022 | $184,166 | $224,638 |
| Exchange Rate Effect | 3,255 | 3,571 | 2,110 | -3,157 | 2,399 |
| Beginning Cash Position | 445,615 | 445,615 | 445,615 | 95,881 | 95,881 |
| End Cash Position | 428,874 | 285,395 | 449,677 | 445,615 | 420,065 |
| Net Cash Flow | $-16,741 | $-160,220 | $4,062 | $349,734 | $324,184 |
| Free Cash Flow | |||||
| Operating Cash Flow | -152,621 | -117,974 | -34,554 | -183,489 | -139,080 |
| Capital Expenditure | -9,612 | -6,477 | -3,194 | -25,010 | -19,597 |
| Free Cash Flow | -162,233 | -124,451 | -37,748 | -208,499 | -158,677 |